<DOC>
	<DOCNO>NCT00104455</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The purpose trial investigate dose response recombinant factor VIIa healthy volunteer administer bleed .</brief_summary>
	<brief_title>Dose Response Recombinant Factor VIIa When Administered Bleed</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Ages Eligible Study : 18 Years 60 Years</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>rFVIIa</keyword>
	<keyword>Punch Biopsy</keyword>
	<keyword>Dose Response</keyword>
	<keyword>Healthy People Programs</keyword>
</DOC>